key: cord-0875084-n38l7c21
authors: Mohapatra, Debabrata; Prabhakar, Prashant; Seth, Rachna; Meena, Jagdish Prasad; Gupta, Aditya Kumar
title: Predictors of poor outcome in COVID 19 infection, in a cohort of pediatric cancer patients, during the second wave in India
date: 2021-12-31
journal: Pediatric Hematology Oncology Journal
DOI: 10.1016/j.phoj.2022.03.165
sha: 71854aeeff23662812e049b4ee17a980b56cebb8
doc_id: 875084
cord_uid: n38l7c21

nan

Introduction: In the era of COVID 19 pandemic there is upsurge in mucormycosis. While there are no published cases in India, We report a child on ALL induction with COVID who later had Primary Cutaneous Mucormycosis(PCM). Case report: At diagnosis of standard risk B ALL, child had mild COVID infection with elevated inflammatory markers and normal CT chest. He received symptomatic management for COVID and half the induction dose steroids alone for one week. Once he tested negative for COVID he was started with four drug induction chemotherapy. He was normoglycemic during induction. After receiving 18 days steroids, 3 doses vincristine, 2 doses daunomycin and pegasparaginase, he had 6x6cm unhealthy punched out wound with erythematous necrotized edges and serosanguinous discharge, at the adhesive tape site, 10cm distal to PICC line entry in right forearm(figure). The wound was debrided ĂChemotherapy was withheld and started with therapeutic dose of Oral Posaconazole suspension. Histopathology revealed necrotic adipose tissue and broad, aseptate hyphae with vascular invasion suggestive of mucormycosis. Twice daily saline dressing was done and wound healed over a period of 4 weeks. Oral Posaconazole was continued for total of 6 weeks duration. In induction chemotherapy one week of steroids and one dose of Vincristine were withheld in view of infection and drug interaction. Postinduction Bone marrow(BM) was in remission and BM MRD was 0.04%. He then received completed consolidation chemotherapy. Postconsolidation BM MRD was < 0.01%. Hence continued with further chemotherapy as per protocol. Conclusion: Early diagnosis, antifungal therapy, surgical debridement and modifying the prior immunosuppressants are necessary to salvage patients with mucormycosis.

Aditya Dabas, Neha Goel, Rani Gera, Amitabh Singh * . Department of Paediatrics, VMMC and Safdarjung Hospital, New Delhi * Corresponding author ABSTRACT Background and aims: Acute leukemia in children is associated with significant treatment-related mortality, most commonly due to infectious causes. Febrile Neutropenia (FN) remains the most common and lifethreatening complication of chemotherapy that results in increased hospitalization and stay and delay the treatment. However, mortality rates and predictors of mortality in FN are not well established in the pediatric literature. The study aims to identify the predictors of mortality in children (1-12 years) with cancer developing febrile neutropenia. Methods A prospective cohort observational study was carried out in tertiary care super-specialty hospital from 1st November 2019 to 31st march 2021 on children aged 1-12 years with cancer undergoing chemotherapy who presented with a documented fever of more than equal to 38'C for at least 1 hour and absolute neutrophilic count of less than 500/uL at diagnosis or within 24 hours of admission. Children with the absence of documented fever at the time of diagnosis were excluded. The data were analysed with SPSS statistics. Results The majority of patients (64.1%) were B-cell ALL. Mean hospital stay was less than 10 days (61.8%). In-hospital mortality was 9.2%. 79.4% of patients presented within 72 hours of receiving chemotherapy and 62.6% had no localizing signs. 46.6% had grade II malnutrition. 14.5% showed blood culture positivity. Most common organism in day 1 blood culture was Acenitobacter baumani (31.6%) and on day 3 blood culture was klebseilla pneumonia (40%). The organisms were resistant to cefaperazone (88.9%), ceftriaxone (92.5%) and linezolid (81.5%). Mean PCT was 4.51 ± 10.55, mean ANC was 364.56 ± 303.15. Conclusion: Malnutrition, duration of hospital stay, hemodynamic instability, and procalcitonin levels, absolute neutrophil count were independent risk factors of mortality. Overall mortality in our study was 9.1 %. In LMIC, mortality remains high due to poor sanitation, low education level of population, poor socio-economic status. ABSTRACT: Background and aim: The second wave of COVID 19, far outnumbered the first, in terms of cases and deaths, resulting in more than 17 million cases and about 0.2 million deaths. Global data has been variable with respect to mortality (0-6.6%). We report outcome of patients with COVID-19 during the second wave, from the pediatric oncology unit of a tertiary center in India to highlight the risk factors contributing to poor outcome. Methods: Pediatric cancer patients, testing positive for SARS-CoV-2 were enrolled. Data on symptoms, hematological/inflammatory parameters, treatment and outcome was collected. All cases were followed up till tested negative. Results: Forty-one patients (23 ALL, 5 Ewing sarcoma, 3 retinoblastoma, 2 each of AML/Neuroblastoma/Non-Hodgkin lymphoma and 1 each of Hodgkin lymphoma/LCH/ Rhabdomyosarcoma/Nasopharyngeal carcinoma) tested positive for SARS-CoV-2 by RT-PCR/ CBNAAT/Rapid Antigen Test/CT-severity score. While more than half were asymptomatic, 36% had mild symptoms. Twenty-five (60.9%) patients were sent on home isolation, 12 were admitted in COVID ward and 4 in intensive care. Out of 5 patients that required supplemental oxygen, 4 needed mechanical ventilation. Systemic steroids and Remdesivir were given in 4 and 2 patients respectively. While hematological parameters were normal in majority, the inflammatory markers: CRP, Ferritin, IL-6 and D-dimer were elevated. The mean time to negativity was 18 days. Of the 4 deaths (Table 1 ), 3 occurred in adolescent age group and 2 had superimposed bacterial/viral infections. Two patients were treated with IVIG for MIS-C. Additional contributors to mortality include: severe thinness/ superior mediastinal syndrome/ disease relapse. Conclusions: Pediatric cancer patients in developing countries might be at increased risk of severe disease and death. Poor prognostic factors identified in our study include: adolescence, cancer cachexia, airway obstruction, disease relapse and superinfections. Background and aim: Micronutrient deficiencies like folate, vitamin B12 have been studied sparingly in pediatric malignancies. Literature suggests higher incidence of treatment related morbidity & mortality in pediatric cancer patients with vitamin b12 and folate deficiency .Our study was aimed to detect the prevalence of serum vitamin B12, folate deficiency in children with malignancy and association with short term morbidities between children with and without deficiencies Methodology: A prospective observational study was done from January 2018 -March 2019. Children less than 12 years, diagnosed with a malignancy were evaluated for vitamin B12 and red cell folate levels at diagnosis and were followed up for 6 months to assess (i) need for blood transfusion, (ii) platelet transfusion, (iii) number of admissions for febrile neutropenia. Children of similar age group attending out -patient clinic who has recovered from the previous illness were enrolled as controls. Results: A total of 72 patients and 40 controls were enrolled and evaluated. Children with malignancy had a vitamin B12 deficiency of 15 % compared to 10 % in the control population which was not statistically significant (p¼0.43).Only one child had RBC folate deficiency. Out of the children who had deficiency 64 % were undernourished and all were on vegetarian diet. No difference was observed in requirement for blood transfusions (p¼0.968), platelet transfusions (p¼ 0.467), number of episodes of febrile neutropenia (p¼0.336) between the groups with and without B12/Folate deficiency. However, Patients with undernutrition had greater requirement for blood transfusions (p¼0.002), platelet transfusions (p¼0.001) and number of episodes of febrile neutropenia (p¼0.002) Conclusions: Undernutrition is a modifiable risk factor. Two third of children with B12 /folate deficiency were undernourished signifying the importance of under nutrition, to be the root cause of deficiency and the associated morbidities, needing attention and intervention at a community level. Contrast enhanced computed tomography (CECT) showed bilateral patchy areas of consolidation. Serum Galactomannan assay was 0.85. The patchy consolidation resolved after four weeks of Amphotericin B deoxycholate therapy. In retrospect it was noticed that there was rapid recovery of neutrophil counts from 500cells/uL to 1500cells/uL within 48 hours when child developed pneumothorax. At the end of induction minimal residual disease (EOI-MRD) was <0.01%.

A nine year old girl was diagnosed with B-ALL having hyperdiploidy. On day 30 of induction, child developed pleuritic chest pain on the right side. Chest radiograph suggested right pneumothorax which was confirmed on CECT thorax. There were multiple ill-defined heterogeneously enhancing nodules of varying size in bilateral lung fields in random distribution. Few cavitary lung lesions were seen in the anterior basal segment of right lower lobe. Serum Galactomannan was positive (2.11). Child was started on Amphotericin B deoxycholate. There was a recent neutrophil count recovery from 600 to 1100cells/uL when child had developed pneumothorax. Child was able to achieve anEOI-MRD of <0.01%. Case C A nine year old boy was diagnosed with B-ALL. On day 28 of induction, child developed chest pain on deep inspiration. Chest radiography showed collapse of right lung with lucent area in peripheral lung field with absent broncho-vesicular marking suggesting a pneumothorax. Needle decompression of pleural space was done followed by chest tube thoracotomy. CECT thorax showed patchy areas of consolidation in right lower lobe. Serum Galactomannan assay was 1.2. Child responded well after three weeks of amphotericin B and achieved negative EOI-MRD. Discussion: The German ALL-Berlin-Frankfurt-Muenster (BFM) study group reported that fungal infections were responsible for one-fifth of fatal infections in pediatric ALL patients. Aspergillus was implicated in two thirds of those with invasive fungal infection. Corticosteroids and prolonged neutropenia are known risk factors for invasive fungal infection. 1-Corticosteroids may mask the common presenting symptoms of IPA, mainly fever and cough. The occurrence of spontaneous pneumothorax may be the first manifestation of sub-pleural fungal infection in patients with leukemia. 2 A temporal correlation between neutrophil count recovery and occurrence of pneumothorax in patients with invasive fungal pneumonia has been demonstrated earlier 3 and observed in two of our cases Conclusion: A possibility of IPA should be considered when encountered with pneumothorax in children with leukemia on intensive chemotherapy. Conflicts of interest: None. 

Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL: Fungal infections in children with ALL

Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey